Health
Breakthrough Cancer Vaccine Shows 93% Efficacy in Phase III Trials
A personalized mRNA cancer vaccine has shown 93% efficacy in preventing recurrence.
Latest Health coverage.
A personalized mRNA cancer vaccine has shown 93% efficacy in preventing recurrence.
Before celebrating human-level diagnostic AI, we need an honest conversation about liability and bias.
The WHO formally declared the end of COVID-19 as a global public health emergency.